Yi‐Ming Chen

Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial

Michael Wang, Luis Fayad, Nicolaus A. Wagner‐Bartak et al. · The Lancet Oncology · 2012 · 296 citations

Phase 1/2, Lymphoid Neoplasia, Hematological Malignancy +8

Cell Sorting Experiments Link Persistent Mitochondrial DNA Damage with Loss of Mitochondrial Membrane Potential and Apoptotic Cell Death

Janine H. Santos, Ľuba Hunáková, Yi‐Ming Chen et al. · Journal of Biological Chemistry · 2003 · 209 citations · Full text

Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy

Der‐Yuan Chen, Yi‐Ming Chen, Hsin‐Hua Chen et al. · Arthritis Research & Therapy · 2011 · 207 citations · Full text

Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study

Tai-Ming Ko, Chang‐Youh Tsai, Shih-Yang Chen et al. · BMJ · 2015 · 197 citations · Full text

Association between a history of periodontitis and the risk of rheumatoid arthritis: a nationwide, population-based, case–control study

Hsin‐Hua Chen, Nicole Huang, Yi‐Ming Chen et al. · Annals of the Rheumatic Diseases · 2012 · 175 citations